Skip to main content
. 2020 Jul 26;34(9):e23374. doi: 10.1002/jcla.23374

Figure 4.

Figure 4

Kaplan‐Meier survival analysis. A, 3‐y overall survival of CML patients, according to P‐gp expression. B, 3‐y progression‐free survival of CML patients, according to P‐gp expression. C, 3‐y achievement of major molecular response of CML patients, according to P‐gp. Kaplan‐Meier analysis demonstrating the results of the P‐gp level measured by flow cytometry using monoclonal antibodies as described in Materials and methods. CML, chronic myeloid leukemia; P‐gp, P‐glycoprotein